Page 6 - Flipbook

• 74,968 women underwent SUI surgery

during the study period

• 5,505,576 women in the control group

• Median FU of 8.5 yrs (IQR, 5.5–11.9)

• 587 pelvic malignancies occurred

in the surgery group

• Women who underwent SUI

surgery had a reduced risk of

pelvic malignancy independent

of surgery type, compared to

controls (Wald type 3 p <0.001; mesh HR, 0.68
[95% CI, 0.62–0.76]; p <0.0001; nonmesh HR, 0.37
[95% CI, 0.29–0.46]; p <0.0001).

J Urol 2021; 205: 1725-1732